Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy

Geert C. van Almen, Melissa Swinnen, Paolo Carai, Wouter Verhesen, Jack P. M. Cleutjens, Jan D'hooge, Fons K. Verheyen, Yigal M. Pinto, Blanche Schroen, Peter Carmeliet, Stephane Heymans*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

33 Citations (Web of Science)
Original languageEnglish
Pages (from-to)318-328
JournalJournal of Molecular and Cellular Cardiology
Issue number3
Publication statusPublished - Sep 2011


  • Akt
  • Cardiomyopathy
  • Doxorubicin
  • Extracellular matrix
  • Thrombospondin-2

Cite this